Startups Archives - Penn Center for Innovation

Paradigm Shift: A Penn engineer pivots to a career in health tech

Posted on July 9, 2020 — Jessica Jones Gupta

Before becoming the first full time employee of Paradigm Surgical, Jonathan Sanchez was a Penn Engineering undergrad searching for a side project to explore his interest in CAD. Six years later, Jonathan is the Lead Product Design Engineer for the five year old medical device startup. In our interview below, Jonathan walks us through how…

Spinout Stories: Paradigm Surgical

Posted on June 24, 2020 — Jessica Jones Gupta

In our Spinout Stories blog series, PCI features a Penn-affiliated company that leveraged programs like PCI Ventures and I-Corps on their path to commercialization. Paradigm Surgical is one such startup success story. What started as an idea in Dr. John Fischer’s lab to improve abdominal surgery for hernias, is now a five year old medical…

First-of-its-kind engineered macrophage cell therapy platform shows ability to reduce tumor burden and activate anti-tumor immunity

Posted on April 2, 2020 — Jessica Jones Gupta

Study highlights previously untapped potential of genetically engineered macrophages in immunotherapy for solid tumors Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Nature Biotechnology has published a study from the Perelman School of Medicine at the University of Pennsylvania demonstrating Carisma’s foundational technology evaluating the potential of human chimeric antigen receptor…

Dock Street Brewery makes world’s first drone-assisted beer in Philly

Posted on January 10, 2020 — Jessica Jones Gupta

Philadelphia is a proud city of firsts, and now we can lay claim to the first drone-assisted beer. Dock Street Brewery, one of the country’s first post-Prohibition craft microbreweries, has partnered with Point Breeze neighbor Exyn Technologies (and Penn spinout) on the Dock Street Swarm Intelligence Pale Ale. Read More on the Philadelphia Voice

NextUp: The Penn spinout inventing the next generation of surgical rools

Posted on January 6, 2020 — Jessica Jones Gupta

Verix Health is developing a suite of steerable surgical needles to enable minimally invasive treatment of hard-to-reach cancer tumors. Read More (On Philadelphia Magazine online)

Nominate for the Life Sciences PA Annual Awards

Posted on November 26, 2019 — Jessica Jones Gupta

Each of the awards presented at the Life Sciences PA Annual Dinner recognizes a contribution that helped shape the life sciences industry into what it is today. This is your chance to tell us who you believe should be honored at this year’s Annual Dinner. Emerging Company of the Year Life Sciences Pennsylvania’s Emerging…

Positive results in first-in-U.S. trial of CRISPR-edited immune cells

Posted on November 8, 2019 — Jessica Jones Gupta

Genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology, then infusing those cells back into the patient appears safe and feasible based on early data from the first-ever clinical trial to test the approach in humans in the United States. Researchers from the Abramson Cancer Center have infused three participants in the trial thus far—two…

JPOD @ Philadelphia, 365 days later

Posted on November 6, 2019 — Jessica Jones Gupta

One year after the launch of the partnership between Penn and Johnson & Johnson Innovation, the Pennovation Center celebrated the early successes of this innovative program. Read more. (Penn Today)

More Philly tech graduates are staying here. That’s a good thing.

Posted on October 25, 2019 — Jessica Jones Gupta

When it comes to high tech, Philadelphia is no Silicon Valley. We’re not even Boston’s Route 128, bumptiously designated “America’s Technology Region.” But Vijay Kumar, a professor at the University of Pennsylvania School of Engineering, is optimistic about the region’s future as a high-tech center. “I think we are hitting an inflection point in the…

Philadelphia biotech firm spun out of Penn goes public in $74.8M IPO

Posted on — Jessica Jones Gupta

Philadelphia’s Cabaletta Bio Inc. raised $74.8 million in an initial public offering Friday, becoming the region’s first life sciences IPO of 2019. The University of Pennsylvania spinout company sold 6.8 million shares of common stock at $11 per share. Read More on Bizjournals.com

News Archive

Penn Center for Innovation

Pci News: Startups